Audited information

Clariant has grouped its activities into four (reportable segments): Care Chemicals (BU ICS), Catalysis (BU ), Natural Resources (BU Oil & Mining Services, BU Functional Minerals) and Plastics & Coatings (BU , BU , BU ). The Energy Storage business which pertained to the BA Catalysis was sold in 2015.

Intersegment transactions are entered into under the normal circumstances and terms and conditions that would also be available to unrelated third parties.

Segment assets consist of property, plant and equipment, goodwill, intangible assets, inventories, receivables and investments in associates. They exclude deferred tax assets, financial assets and operating cash. Segment liabilities comprise trade payables. They exclude items such as tax liabilities, provisions, pension liabilities and corporate borrowings. Capital expenditure comprises additions to property, plant and equipment and intangibles.

In the context of the rearrangement of its portfolio of business activities, Clariant disposed the Leather Services business as per 30 April 2014. For these reasons, up to the transaction closing date, this business was reported as discontinued operations in the financial report.

On 28 February 2015, Clariant sold its Energy Storage Activities pertaining to the Business Area Catalysis to the UK-based Johnson Matthey. Therefore, the related assets and liabilities are reported as held for sale at the end of 2014.

Segments

in CHF m

 

Care Chemicals

 

Catalysis

 

Natural Resources

 

Plastics & Coatings

 

Total segments

 

Corporate

 

Total Group

 

 

2015

 

2014

 

2015

 

2014

 

2015

 

2014

 

2015

 

2014

 

2015

 

2014

 

2015

 

2014

 

2015

 

2014

1

EBITDA is earning before interest, tax, depreciation and amortization.

Segment sales

 

1 446

 

1 514

 

704

 

729

 

1 219

 

1 300

 

2 458

 

2 599

 

5 827

 

6 142

 

 

 

 

5 827

 

6 142

Sales to other segments

 

–1

 

–3

 

 

 

 

–2

 

–3

 

–17

 

–20

 

–20

 

–26

 

 

 

 

–20

 

–26

Total sales

 

1 445

 

1 511

 

704

 

729

 

1 217

 

1 297

 

2 441

 

2 579

 

5 807

 

6 116

 

 

 

5 807

 

6 116

Operating expenses

 

–1 225

 

–1 302

 

–565

 

–646

 

–1 044

 

–1 234

 

–2 230

 

–2 314

 

–5 064

 

–5 496

 

–247

 

–95

 

–5 311

 

–5 591

Thereof:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Income from associates and joint ventures

 

9

 

9

 

18

 

17

 

9

 

3

 

30

 

35

 

66

 

64

 

11

 

11

 

77

 

75

Gain from disposals not qualifying as discontinued operations

 

 

 

 

12

 

 

 

3

 

5

 

 

 

 

15

 

5

 

 

163

 

15

 

168

Restructuring, impairment and transaction-related costs

 

–6

 

–2

 

 

–30

 

–1

 

–96

 

–23

 

–10

 

–30

 

–138

 

–85

 

–90

 

–115

 

–228

Operating income

 

220

 

209

 

139

 

83

 

173

 

63

 

211

 

265

 

743

 

620

 

–247

 

–95

 

496

 

525

Net financial expenses and taxes

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

–269

 

–290

Net result from continuing operations

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

227

 

235

Result from discontinued operations

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

12

 

–18

Net income

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

239

 

217

Segment assets

 

982

 

1 014

 

1 631

 

1 627

 

872

 

997

 

1 700

 

1 889

 

5 185

 

5 527

 

 

 

 

 

5 185

 

5 527

Segment liabilities

 

–200

 

–224

 

–123

 

–107

 

–109

 

–135

 

–228

 

–226

 

–660

 

–692

 

 

 

 

 

–660

 

–692

Net operating assets

 

782

 

790

 

1 508

 

1 520

 

763

 

862

 

1 472

 

1 663

 

4 525

 

4 835

 

 

 

4 525

 

4 835

Net assets held for sale

 

 

 

 

62

 

 

 

2

 

2

 

2

 

64

 

 

–2

 

2

 

62

Corporate assets without cash

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

1 333

 

1 388

 

1 333

 

1 388

Corporate liabilities without financial liabilities

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

–2 054

 

–2 289

 

–2 054

 

–2 289

Net debt2

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

–1 312

 

–1 263

 

–1 312

 

–1 263

Total net assets

 

782

 

790

 

1 508

 

1 582

 

763

 

862

 

1 474

 

1 665

 

4 527

 

4 899

 

–2 033

 

–2 166

 

2 494

 

2 733

Thereof:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Investments in PPE and intangibles for the period

 

97

 

90

 

148

 

49

 

33

 

38

 

78

 

79

 

356

 

256

 

45

 

65

 

401

 

321

Investments in associates and joint ventures at the end of the period

 

57

 

59

 

187

 

200

 

15

 

19

 

143

 

165

 

402

 

443

 

184

 

192

 

586

 

635

Reconciliation of key figures

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating income

 

220

 

209

 

139

 

83

 

173

 

63

 

211

 

265

 

743

 

620

 

–247

 

–95

 

496

 

525

Add: systematic depreciation of PPE

 

42

 

44

 

33

 

38

 

24

 

26

 

68

 

74

 

167

 

182

 

36

 

39

 

203

 

221

Add: impairment

 

 

 

 

30

 

 

87

 

13

 

 

13

 

117

 

1

 

–1

 

14

 

116

Add: amortization of intangible assets

 

4

 

4

 

17

 

20

 

11

 

11

 

11

 

11

 

43

 

46

 

11

 

15

 

54

 

61

EBITDA1

 

266

 

257

 

189

 

171

 

208

 

187

 

303

 

350

 

966

 

965

 

–199

 

–42

 

767

 

923

Add: restructuring, impairment and transaction-related costs

 

6

 

2

 

 

30

 

1

 

96

 

23

 

10

 

30

 

138

 

85

 

90

 

115

 

228

Less: impairment (reported under restructuring and impairment)

 

 

 

 

–30

 

 

–87

 

–13

 

 

–13

 

–117

 

–1

 

1

 

–14

 

–116

Less: gain from disposals not qualifying as discontinued operations

 

 

 

–12

 

 

–3

 

–5

 

 

 

–15

 

–5

 

 

–163

 

–15

 

–168

EBITDA before exceptional items

 

272

 

259

 

177

 

171

 

206

 

191

 

313

 

360

 

968

 

981

 

–115

 

–114

 

853

 

867

Operating income

 

220

 

209

 

139

 

83

 

173

 

63

 

211

 

265

 

743

 

620

 

–247

 

–95

 

496

 

525

Add: restructuring, impairment and transaction-related costs

 

6

 

2

 

 

30

 

1

 

96

 

23

 

10

 

30

 

138

 

85

 

90

 

115

 

228

Less: gain from disposals not qualifying as discontinued operations

 

 

 

–12

 

 

–3

 

–5

 

 

 

–15

 

–5

 

 

–163

 

–15

 

–168

Operating income before exceptional items

 

226

 

211

 

127

 

113

 

171

 

154

 

234

 

275

 

758

 

753

 

-162

 

-168

 

596

 

585

2 Calculation of net debt

in CHF m

 

31.12.2015

 

31.12.2014

Non-current financial debt

 

1 859

 

1 761

Add: current financial debt

 

394

 

430

Less: cash and cash equivalents

 

–789

 

–748

Less: Near-cash assets

 

–152

 

–180

Net debt

 

1 312

 

1 263

Reconciliation of segment assets to total assets

in CHF m

 

31.12.2015

 

31.12.2014

Segment assets

 

5 185

 

5 527

Segment assets reported as assets held for sale

 

2

 

66

Corporate assets reported as assets held for sale

 

 

6

Corporate assets without cash

 

1 333

 

1 388

Cash

 

789

 

748

Near-cash assets

 

152

 

180

Total Assets

 

7 461

 

7 915

Geographic information

in CHF m

 

Sales1

 

Non-current assets2

 

 

2015

 

2014

 

31.12.2015

 

31.12.2014

1

Allocated by region of third-party sale’s destination.

2

Non-current assets exclude deferred tax assets and pension plan assets.

EMEA

 

2 336

 

2 693

 

2 484

 

2 802

of which Germany

 

654

 

809

 

1 559

 

1 968

of which Switzerland

 

38

 

50

 

574

 

459

of which MEA

 

405

 

461

 

71

 

83

North America

 

1 077

 

1 006

 

893

 

805

of which USA

 

981

 

902

 

872

 

779

Latin America

 

1 021

 

984

 

224

 

268

of which Brazil

 

336

 

405

 

110

 

138

Asia/Pacific

 

1 373

 

1 433

 

495

 

395

of which China

 

450

 

519

 

217

 

182

of which India

 

159

 

141

 

63

 

62

Total

 

5 807

 

6 116

 

4 096

 

4 270

All of the Group’s segments generate their revenues to the largest extent from the sale of products. These come in such a great variety that a meaningful grouping below the segment information is not possible. The amounts reported for sales cover only continuing operations for both years.

For a description of the Business Units see .

Business area

In 2013 Clariant adjusted its reporting segments and grouped its businesses with similar end-user markets and growth drivers. Today, the company reports in four distinct Business Areas: Care Chemicals, Catalysis, Natural Resources, and Plastics & Coatings. VIEW ENTIRE GLOSSARY

Catalyst

A substance that lowers the activation energy, thereby increasing the rate of a chemical reaction without being consumed by the reaction itself (Clariant Business Unit Catalysts). VIEW ENTIRE GLOSSARY

Additive

A substance added to products in small quantities to achieve certain properties or to improve a product (Clariant Business Unit Additives). VIEW ENTIRE GLOSSARY

Masterbatches

These are plastic additives in the form of granules with dyestuffs or other additives used to dye or alter the properties of natural plastic. VIEW ENTIRE GLOSSARY

Pigment

Pigments are substances used for coloring; they are used in a technical manner, for example in the manufacture of dyes, varnishes, and plastics. VIEW ENTIRE GLOSSARY

FURTHER READING